Aprea Therapeutics, Inc. (APRE)
NASDAQ: APRE · Real-Time Price · USD
0.7892
+0.0092 (1.18%)
Sep 24, 2026, 12:25 PM EDT - Market open
Aprea Therapeutics Market Cap
Aprea Therapeutics has a market cap or net worth of $9.94 million as of September 24, 2026. Its market cap has increased by 18.46% in one year.
Market Cap
9.94M
Enterprise Value
-31.30M
1-Year Change
18.46%
Ranking
Category
Stock Price
$0.79
ChartMarket Cap Chart
Since May 27, 2022, Aprea Therapeutics's market cap has decreased from $18.94M to $9.94M, a decrease of -47.52%. That is a compound annual growth rate of -13.83%.
| Date | Market Cap | % Change |
|---|---|---|
| Sep 24, 2026 | 9.94M | 66.57% |
| Dec 31, 2025 | 5.97M | -66.64% |
| Dec 31, 2024 | 17.88M | 1.81% |
| Dec 29, 2023 | 17.56M | 0.11% |
| Dec 30, 2022 | 17.54M | -7.36% |
| May 27, 2022 | 18.94M | - |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Related Stocks
| Company | Market Cap |
|---|---|
| CytoMed Therapeutics | 10.77M |
| Purple Biotech | 10.76M |
| MetaVia | 10.74M |
| Adial Pharmaceuticals | 10.61M |
| Immuron | 10.56M |
| Senti Biosciences Holdings | 10.53M |
| Moleculin Biotech | 10.28M |
| Azitra | 10.03M |